Sign in / Join Now
ETFs & Funds
, article soon on $
. 2 catalysts, strong cash position, low burn, 250M potential revenue, 270M market cap
Add a reply...
Latest StockTalks »
people get SCMP breaking news and analysis by email alert.
Get email alerts on SCMP »
Sucampo Pharmaceuticals, Inc.
Get latest price
From other sites
Sucampo Reports Second Quarter 2016 Financial Results
at TheStreet (Aug 3, 2016)
Paul Edick Joins Sucampo's Board Of Directors
at TheStreet (Jul 29, 2016)
Sucampo to Stop Developing Cobiprostone for Oral Mucositis
at Zacks.com (Jul 12, 2016)
The Zacks Analyst Blog Highlights: Acacia Research, CalAmp, Renewable Energy Group and Sucampo Pharmaceuticals
at Zacks.com (Apr 1, 2016)
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Corcept Therapeutics, Sucampo Pharmaceuticals and Actelion
at Zacks.com (Mar 18, 2016)